Webinar

Heart Failure is progressive disease state previously manageable only by guideline directed medical therapy (GDMT). This webinar will give an overview of CCM® therapy, the indications for use, and the clinical studies leading to the breakthrough device approval from the FDA. Case studies will be shown to emphasize the need for patient screening, as well as give the audience real world examples of how to implement CCM® therapy in your practice and access to your patients.

Heart Failure is a progressive disease state previously manageable only by guideline directed medical therapy (GDMT). Many patients are often left without options in their heart failure treatment and require additional screening to determine whether they are a candidate for available device therapy. This webinar will give an overview of the Optimizer® CCM® therapy delivery system, the indications for use, and share best practices on how to screen patients that may benefit from CCM®. Case studies will be shown to emphasize the need for patient screening, as well as give the audience real world examples of how to implement CCM® therapy in your practice and access to your patients.